SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001698530-24-000117
Filing Date
2024-11-14
Accepted
2024-11-14 16:38:37
Documents
78
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q xcur-20240930.htm   iXBRL 10-Q 1000831
2 EX-10.1 exicureexhibit101.htm EX-10.1 84905
3 EX-31.1 exicureexhibit311-93024.htm EX-31.1 7752
4 EX-31.2 exicureexhibit312-93024.htm EX-31.2 7764
5 EX-32.1 exicureexhibit321-93024.htm EX-32.1 8240
  Complete submission text file 0001698530-24-000117.txt   5837885

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xcur-20240930.xsd EX-101.SCH 50936
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xcur-20240930_cal.xml EX-101.CAL 52460
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xcur-20240930_def.xml EX-101.DEF 178938
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xcur-20240930_lab.xml EX-101.LAB 618042
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xcur-20240930_pre.xml EX-101.PRE 407130
81 EXTRACTED XBRL INSTANCE DOCUMENT xcur-20240930_htm.xml XML 577367
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1700
EXICURE, INC. (Filer) CIK: 0001698530 (see all company filings)

IRS No.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39011 | Film No.: 241463493
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)